Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic.
Lancet Oncol
; 23(2): 195-197, 2022 02.
Article
in English
| MEDLINE | ID: covidwho-1661932
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Limits:
Humans
Language:
English
Journal:
Lancet Oncol
Journal subject:
Neoplasms
Year:
2022
Document Type:
Article
Affiliation country:
S1470-2045(21)00708-7
Similar
MEDLINE
...
LILACS
LIS